Braiin (NASDAQ:BRAI) Trading Up 5.2% – Time to Buy?

Braiin Ltd (NASDAQ:BRAI)’s stock price traded up 5.2% during trading on Wednesday . The stock traded as high as $5.60 and last traded at $5.7320. Approximately 12,609 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 252,355 shares. The stock had previously closed at $5.45.

Braiin News Summary

Here are the key news stories impacting Braiin this week:

• Neutral Sentiment: Google’s mapping of a fruit fly’s brain and experiments using the digital model in video games highlight advances in computational neuroscience and artificial intelligence. The research could support long-term interest in brain-related technology, but it has no disclosed connection to Braiin Ltd. Google Mapped a Fruit Fly’s Brain. Now It’s Playing Doom and Super Mario 64
• Neutral Sentiment: Apple’s acquisition of a brain-imaging company underscores rising corporate interest in health monitoring, accessibility and neural data. It may increase attention on the broader sector, but it also demonstrates the scale of competition from major technology companies. Apple acquires brain imaging firm for health and accessibility features
• Neutral Sentiment: Reports on Temple’s ability to track brain blood flow, along with studies on exercise, Alzheimer’s disease, pregnancy-related anemia and brain vascular cells, add to the flow of neuroscience research. None reports a partnership, product launch, funding event or clinical result involving BRAI. Deepinder Goyal Says Temple Can Track Brain Blood Flow Better Than Heart Rate Alone
• Neutral Sentiment: Articles challenging assumptions about decision-making, spirituality and brain development are primarily educational and unlikely to affect Braiin Ltd’s near-term valuation. A Neuroscientist Says Your Brain May Not Actually Make Decisions

Analyst Ratings Changes

Several analysts have weighed in on the company. Maxim Group initiated coverage on Braiin in a research report on Monday, June 15th. They set a “buy” rating and a $10.00 price objective on the stock. Zacks Research upgraded Braiin to a “hold” rating in a research report on Tuesday, June 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Braiin in a research note on Monday, August 3rd. Finally, Wall Street Zen upgraded Braiin from a “sell” rating to a “hold” rating in a report on Sunday, May 31st. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $10.00.

Braiin Stock Performance

The stock has a 50-day moving average of $5.64 and a two-hundred day moving average of $6.93.

Braiin Company Profile

Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.